Yahoo Web Search

Search results

  1. 19 hours ago · Jazz Pharmaceuticals is a biopharmaceutical company that develops and commercializes products for various neurological and oncology conditions. See its stock price, financial results, news, events, and analyst ratings on Stock Analysis.

  2. 5 days ago · The high in the last 52 weeks of Jazz Pharmaceuticals stock was 146.47. According to the current price, Jazz Pharmaceuticals is 72.41% away from the 52-week high. What are analysts forecasts...

  3. People also ask

  4. May 3, 2015 · 13 analysts have issued 12 month target prices for Jazz Pharmaceuticals' stock. Their JAZZ share price targets range from $131.00 to $230.00. On average, they predict the company's stock price to reach $192.75 in the next twelve months. This suggests a possible upside of 83.5% from the stock's current price.

    • investorinfo@jazzpharma.com
  5. May 23, 2024 · Jazz Pharmaceuticals PLC. + Add to watchlist. JAZZ:NSQ. Actions. Price (USD) 103.94. Today's Change -1.57 / -1.49% Shares traded 796.30k. 1 Year change -20.28% Beta 0.6155. Data delayed at least...

    • 108.27
    • 108.88
    • 111.35
    • 109.27
  6. 3 hours ago · Jazz Pharmaceuticals PLC is a biotechnology company. The Company is engaged in developing medicines for people with serious diseases. The Companyâ s lead marketed products include Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution, Xyrem (sodium oxybate) oral solution, Epidiolex (cannabidiol) oral solution, Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn ...

  7. May 20, 2024 · Jazz Pharmaceuticals plc (JAZZ.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Jazz Pharmaceuticals plc | Nasdaq: JAZZ | Nasdaq.

  8. 6 days ago · Updated May 24, 2024. 3M - 20.12% JAZZ Price. $106.06. Fair Value Price. N/A. Market Cap. $6.69B. 52 Week Low. $103.01. 52 Week High. $146.70. P/E. 20.28x. P/B. 1.81x. P/S. 1.96x. PEG. 0.26x. Dividend Yield. N/A. Revenue. $3.84B. Earnings. $330.79M. Gross Margin. 89.5% Operating Margin. 13.51% Profit Margin. 8.6% Debt to Equity. 2.06.

  1. People also search for